These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1094 related articles for article (PubMed ID: 10601024)

  • 1. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
    Hurlin PJ; Quéva C; Eisenman RN
    Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
    J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
    Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
    EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.
    Farina A; Faiola F; Martinez E
    Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.
    Meroni G; Reymond A; Alcalay M; Borsani G; Tanigami A; Tonlorenzi R; Lo Nigro C; Messali S; Zollo M; Ledbetter DH; Brent R; Ballabio A; Carrozzo R
    EMBO J; 1997 May; 16(10):2892-906. PubMed ID: 9184233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S; Tremblay L; Lavigne P
    J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA binding by N- and L-Myc proteins.
    Ma A; Moroy T; Collum R; Weintraub H; Alt FW; Blackwell TK
    Oncogene; 1993 Apr; 8(4):1093-8. PubMed ID: 8455937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
    Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ; Halazonetis TD
    Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
    Nair SK; Burley SK
    Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network.
    Billin AN; Eilers AL; Coulter KL; Logan JS; Ayer DE
    Mol Cell Biol; 2000 Dec; 20(23):8845-54. PubMed ID: 11073985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.
    Fisher F; Crouch DH; Jayaraman PS; Clark W; Gillespie DA; Goding CR
    EMBO J; 1993 Dec; 12(13):5075-82. PubMed ID: 8262050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
    Grinberg AV; Hu CD; Kerppola TK
    Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.